关于先锋
Company Profile
Focus on the development orientation of generic drugs, aiming at the research and development prospects of chemical generic drugs
Anhui Pioneer Pharmaceutical Co., Ltd. (abbreviation: Anhui Pioneer Pharmaceutical) focuses on the development and orientation of generic drugs, and aims at the prospect of chemical generic drug research and development. Integration is the development model, and a relatively complete scientific research and innovation system has been established.
R&D
Production
Study
Sale
Use
The total area of the research institute is 1000 square meters
Investment in fixed assets exceeds 200 million yuan
Laboratory equipment 50 million yuan
Strength of the research institute
Pioneer Pharmaceutical Research Institute
Anhui Pioneer Pharmaceutical Research Institute covers a total area of 1,000 square meters, with an investment of more than 200 million yuan in fixed assets, including 50 million yuan in laboratory equipment. High-speed centrifuge, automatic SOTAX dissolution apparatus, atomic absorption spectrophotometer and other advanced equipment.
Efficient and reasonable R&D organizational structure
Injection Department
Sustained and controlled release preparation department
Compound preparation department
Technology Transfer Department
Registry

Research team formation and research and development results
A high-level professional research team for analysis and preparation led by doctors and masters has established a liquid preparation laboratory, a solid preparation laboratory, and a pilot test laboratory. It has jointly established high-level innovation platforms such as technology research centers with universities such as University of Traditional Chinese Medicine, Agricultural University, and China Pharmaceutical University. Now it has nearly 40 high-level talents in various drug research and analysis.
Every year, generic drugs in therapeutic fields such as nervous system and cardiovascular system are cultivated, as well as major provincial scientific and technological industrialization projects, and the number is increasing year by year. In 2022, a total of 40 chemical drug research projects will be carried out. A total of 6 items in the first half of 2023.
High-level talents
Invention project
First half of 2023
Beautiful research environment








Generic drug development dosage form
01 Injection dosage form
Aseptic filling preparation
Special line preparation
Small volume injection
Aseptic filling preparation
02 Orally administered preparations
Regular Release Tablets / Capsules
Sustained Release Tablets
Compound Preparation
Dry Suspension
03. Other dosage forms
Topical solution
Patent achievements
Contact us
Add:No.35 HongFeng Road, Hefei, Anhui, China.
Tel:86-551-65355028
Fax:86-551-65355022
Email:xfcn@xfcn.com

Follow us
Copyright © 2023 Anhui Pioneer Pharmaceutical Co., Ltd 皖ICP备2020016893号 Powered by:www.300.cn SEO